Jörg Hockemeyer
About
Jörg Hockemeyer is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, Jörg Hockemeyer has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 17 papers in Molecular Biology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jörg Hockemeyer's work include Adenosine and Purinergic Signaling (24 papers), Receptor Mechanisms and Signaling (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Jörg Hockemeyer is often cited by papers focused on Adenosine and Purinergic Signaling (24 papers), Receptor Mechanisms and Signaling (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Jörg Hockemeyer collaborates with scholars based in Germany, United States and Italy. Jörg Hockemeyer's co-authors include Christa E. Müller, Joachim C. Burbiel, John D. Salamone, Andrew M. Farrar, Sergi Ferré, Marcello Solinas, Davide Quarta, Rodrigo A. Cunha, Lyndsey E. Collins and Russell G. Port and has published in prestigious journals such as International Journal of Molecular Sciences, Neuroscience and Journal of Medicinal Chemistry.
In The Last Decade
Jörg Hockemeyer
40 papers receiving 1.6k citations
Peers
Jörg Hockemeyer
Séverine Chaumont‐Dubel France
Brian Lord United States
Javier Burgueño Spain
Juan F. López‐Giménez United Kingdom
José Luís Albasanz Spain
Víctor Fernández‐Dueñas Spain
Albert Sattin United States
M.B. Emerit France
Éric Boué‐Grabot France
Mairena Martı́n Spain
Citations per year, relative to Jörg Hockemeyer Jörg Hockemeyer (= 1×)
peers
Séverine Chaumont‐Dubel
Countries citing papers authored by Jörg Hockemeyer
Since
Specialization
Citations
This map shows the geographic impact of Jörg Hockemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hockemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hockemeyer more than expected).
Fields of papers citing papers by Jörg Hockemeyer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jörg Hockemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hockemeyer. The network helps show where Jörg Hockemeyer may publish in the future.
Co-authorship network of co-authors of Jörg Hockemeyer
This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Hockemeyer. A scholar is included among the top collaborators of Jörg Hockemeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Hockemeyer. Jörg Hockemeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kubacka, Monika, Szczepan Mogilski, Marek Bednarski, et al.. (2023). Antiplatelet Effects of Selected Xanthine-Based Adenosine A2A and A2B Receptor Antagonists Determined in Rat Blood. International Journal of Molecular Sciences. 24(17). 13378–13378.
2.
Koch, Pierre, Andreas Brunschweiger, Vigneshwaran Namasivayam, et al.. (2018). Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity. Frontiers in Chemistry. 6. 206–206.
3.
Burbiel, Joachim C., Wadih Ghattas, Meryem Köse, et al.. (2016). 2‐Amino[1,2,4]triazolo[1,5‐c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure–Activity Relationships of Potent Adenosine Receptor Antagonists. ChemMedChem. 11(20). 2272–2286.
4.
Brunschweiger, Andreas, Pierre Koch, Muhammad Rafehi, et al.. (2016). 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5462–5480.
5.
Brunschweiger, Andreas, Pierre Koch, Sonja Hinz, et al.. (2014). 8‐Benzyltetrahydropyrazino[2,1‐f]purinediones: Water‐Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases. ChemMedChem. 9(8). 1704–1724.
6.
Koch, Pierre, Andreas Brunschweiger, Thomas Borrmann, et al.. (2013). 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. Bioorganic & Medicinal Chemistry. 21(23). 7435–7452.
7.
Randall, Patrick A., Eric J. Nunes, Colin M. Stopper, et al.. (2011). Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216(2). 173–186.
8.
Collins, Lyndsey E., Daniel J. Galtieri, Patricia Collins, et al.. (2010). Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity. Behavioural Brain Research. 211(2). 148–155.
9.
Pereira, Mariana, Andrew M. Farrar, Jörg Hockemeyer, et al.. (2010). Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat. Psychopharmacology. 213(1). 69–79.
10.
Collins, Lyndsey E., Daniel J. Galtieri, Lise T. Brennum, et al.. (2009). Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX. Pharmacology Biochemistry and Behavior. 94(4). 561–569.
11.
Salamone, John D., Keita Ishiwari, Adrienne J. Betz, et al.. (2008). Dopamine/adenosine interactions related to locomotion and tremor in animal models: Possible relevance to parkinsonism. Parkinsonism & Related Disorders. 14. S130–S134.
12.
Worden, Lila T., Mona Shahriari, Andrew M. Farrar, et al.. (2008). The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology. 203(3). 489–499.
13.
Andrade, Geanne Matos de, Paula M. Canas, Jörg Hockemeyer, et al.. (2007). Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801. Experimental Neurology. 210(2). 776–781.
14.
Farrar, Andrew M., et al.. (2006). Adenosine A2A receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology. 191(3). 579–586.
15.
Burbiel, Joachim C., Jörg Hockemeyer, & Christa E. Müller. (2006). Microwave-assisted ring closure reactions: Synthesis of 8-substituted xanthine derivatives and related pyrimido- and diazepinopurinediones. Beilstein Journal of Organic Chemistry. 2. 20–20.
16.
Burbiel, Joachim C., et al.. (2006). Recent Progress in the Development of Adenosine Receptor Ligands as Antiinflammatory Drugs. Current Topics in Medicinal Chemistry. 6(13). 1375–1399.
17.
Ishiwari, Keita, Andrew M. Farrar, Susana Mingote, et al.. (2006). Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats. Behavioural Brain Research. 178(2). 190–199.
18.
Solinas, Marcello, Sergi Ferré, Κατερίνα Αντωνίου, et al.. (2005). Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats. Psychopharmacology. 179(3). 576–586.
19.
Agnati, Luigi F., Giuseppina Leo, Anna Valeria Vergoni, et al.. (2004). Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson’s disease. Brain Research Bulletin. 64(2). 155–164.
20.
Beckers, Thomas, Thomas Reissmann, Mathias Schmidt, et al.. (2002). 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors.. PubMed. 62(11). 3113–9.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Séverine Chaumont‐Dubel Breakdown of academic impact, for papers by Brian Lord Breakdown of academic impact, for papers by Javier Burgueño Breakdown of academic impact, for papers by Juan F. López‐Giménez Breakdown of academic impact, for papers by José Luís Albasanz Breakdown of academic impact, for papers by Víctor Fernández‐Dueñas Breakdown of academic impact, for papers by Albert Sattin Breakdown of academic impact, for papers by M.B. Emerit Breakdown of academic impact, for papers by Éric Boué‐Grabot Breakdown of academic impact, for papers by Mairena Martı́n